Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Not applicableUnknownNCT06278701
What this trial is testing

The Effect of Late-evening Snacks on Patients With Primary Hepatocellular Carcinoma After Hepatectomy

Who this might be right for
Liver Neoplasms
DU Yao 106
Testing effectiveness (Phase 2)Study completedNCT03163992
What this trial is testing

Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Samsung Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT01508000
What this trial is testing

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Wild Type Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Testing effectiveness (Phase 2)UnknownNCT03851939
What this trial is testing

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 65
Testing effectiveness (Phase 2)Looking for participantsNCT07728019
What this trial is testing

Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM

Who this might be right for
CRC (Colorectal Cancer)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Early research (Phase 1)Looking for participantsNCT04952272
What this trial is testing

Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors

Who this might be right for
Lung CancerHepatocellular CarcinomaSolid Tumor
Second Affiliated Hospital of Guangzhou Medical University 50
Not applicableStudy completedNCT01234701
What this trial is testing

Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)

Who this might be right for
Neoplasms
University of Zurich 108
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Testing effectiveness (Phase 2)Study completedNCT01213030
What this trial is testing

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Who this might be right for
Head and Neck CancerLung CancerLiver Cancer
Siemens Molecular Imaging 12
Large-scale testing (Phase 3)Active Not RecruitingNCT03654053
What this trial is testing

Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis

Who this might be right for
Cirrhosis
VA Office of Research and Development 142
Not applicableLooking for participantsNCT07392567
What this trial is testing

Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer

Who this might be right for
Colorectal Cancer Liver Metastasis
Tongji Hospital 160
Testing effectiveness (Phase 2)Study completedNCT02795429
What this trial is testing

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
Novartis Pharmaceuticals 89
Not applicableActive Not RecruitingNCT07278102
What this trial is testing

A Prospective Observational Study on Efficacy of TARE for Early Stage HCC

Who this might be right for
RadioembolizationHepatocellular Carcinoma (HCC)Early Stage
Seoul National University Hospital 200
Not applicableWithdrawnNCT01831037
What this trial is testing

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
University of Arkansas
Early research (Phase 1)Looking for participantsNCT07391839
What this trial is testing

MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.

Who this might be right for
HepatomaUnresectable Hepatocellular Carcinoma (HCC)
Suzhou Mednovo Yi Medical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)WithdrawnNCT02070419
What this trial is testing

TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaRecurrent Adult Primary Liver CancerStage I Adult Primary Liver Cancer+2 more
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00057382
What this trial is testing

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Tularik 750
Early research (Phase 1)Ended earlyNCT05427396
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

Who this might be right for
Liver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd. 31
Large-scale testing (Phase 3)UnknownNCT05948072
What this trial is testing

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 250
Next Page